Related Funds
Fund Name | Location |
Aishida | China, Wenling, Zhejiang |
American Bailey Ventures | Connecticut, Stamford, United States |
CapitalX | California, San Francisco, United States |
Devonshire Investors | Cambridge, Massachusetts, United States |
El Pais | Community of Madrid, Madrid, Spain |
Founders Equity Partners | California, Palo Alto, United States |
HMG Ventures | - |
Huashu Ziben | Beijing, China, Haidian |
Indiabulls Commercial Credit Ltd. | Gurgaon, Haryana, India |
IndiaNivesh Fund | India, Maharashtra, Mumbai |
Ironweed Capital | California, Palo Alto, United States |
Jeil Technos Co., LTD | - |
Octane Capital Management | California, Mountain View, United States |
OnVista Group | Cologne, Germany, Nordrhein-Westfalen |
Pactolus | Central, Central Region, Singapore |
Product Co-op | California, San Francisco, United States |
Sensinnovat | - |
U.S. Army Combat Capabilities Development Command Army Research Laboratory | Louisiana, Maryland, United States |
Weihe Investment | - |
Xianghe Capital | Beijing, Beijing, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Doctor AI Yisheng Intelligence | 28 Dec 2021 | Haidian, Beijing, China | |||
Geneus | 28 Sep 2021 | Chengdu, Sichuan, China | |||
$12M | 05 May 2021 | Sunnyvale, California, United States | |||
$29M | 20 Dec 2018 | Shanghai, China | |||
OrigiMed | $10M | 20 Sep 2016 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Doctor AI Yisheng Intelligence | 28 Dec 2021 | Haidian, Beijing, China | |||
Geneus | 28 Sep 2021 | Chengdu, Sichuan, China | |||
$12M | 05 May 2021 | Sunnyvale, California, United States | |||
$29M | 20 Dec 2018 | Shanghai, China | |||
OrigiMed | $10M | 20 Sep 2016 | Shanghai, China |